U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT06855576) titled 'Bioequivalence Study of Paracetamol With Oral Single Dose Administration in Healthy Adult Subjects Under Fasting Conditions' on Feb. 28.
Brief Summary: This study aims to evaluate the bioequivalence of new formulated orodispersible tablet (ODT) containing 500 milligram (mg) paracetamol in comparison to the European marketed Alvedon (paracetamol) 500 mg film-coated tablets and the Australian marketed Panadol (paracetamol) 500 mg film-coated tablets as reference products.
Study Start Date: March 03
Study Type: INTERVENTIONAL
Condition:
Fever
Pain
Intervention:
DRUG: Paracetamol ODT
Experimental Paracetamol 500 mg ODT
DRUG: Alv...